Menu

Blog Posts

Industry Insights Logo

Safeguard Your 340B Program and Increase Compliance Through Automated, 100% Audit Workflows

Sponsored Content Views
Join Bluesight’s webinar on August 5 at 1PM ET

SPONSORED CONTENT

The regulatory landscape for the 340B drug pricing program is evolving rapidly. As scrutiny from the Health Resources and Services Administration (HRSA) and drug manufacturers intensifies, healthcare leaders and 340B teams face growing pressure to maintain airtight

…
Read More »

Patient Groups Back Drugmakers in 340B Rebate Appeal, Without Disclosing Drug Industry Funding or Missed Compliance Deadline

William Newton, Associate Editor/Senior Writer Views
Three patient groups recently told a federal appeals court that a 340B rebate model “is essential to the effort to bring transparency to 340B.” One of those groups did not disclose its financial ties to drugmakers, and another is out of compliance with state public reporting laws.
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions

Shannon Young, Associate Editor/Senior Writer Views
Alkermes is one of two drugmakers to recently announce new state exemptions to their 340B contract pharmacy restrictions.
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Merck, Eisai, Vertex to Refund 340B Covered Entities for Overcharges

Shannon Young, Associate Editor/Senior Writer Views
Merck, Eisai and Vertex will refund 340B covered entities that purchased certain medications between 2022 and 2025, according to notices posted on HRSA's website.
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Record Turnout for Fourth Annual ‘Defend 340B’ March on Capitol Hill

William Newton, Associate Editor/Senior Writer Views
340B advocates marched on Capitol Hill to "defend 340B" for the fourth straight summer. (Credit: Community Voices for 340B)
Nearly 80 advocates marched toward Capitol Hill yesterday in a record turnout for the fourth annual “Defend 340B March” in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Budget Reconciliation’s Effects Could Shape Efforts to Reform 340B, Policy Experts Say at 340B Coalition Conference

Shannon Young, Associate Editor/Senior Writer Views
Tom O’Donnell (left) and Michael McCaughan (right) speak at the 340B Coalition Summer Conference in National Harbor, Md.
The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Industry Insights Logo

Separating AI Hype from Real Value in 340B Program Management

Sponsored Content Views
Not all “AI-powered” tools are created equal. Spot what’s useful, what’s fluff, and what to ask vendors next.

SPONSORED CONTENT

AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just marketing is getting blurrier by the day.

We’ve seen AI do

…
Read More »

Analysis: How Medicaid Cuts in ‘Big Beautiful Bill’ Could Push Certain Hospitals Out of 340B and the Importance of Planning Ahead

William Newton, Associate Editor/Senior Writer Views
Experts warn that recently enacted Medicaid cuts could jeopardize some hospitals' 340B eligibility.
Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Colorado, Nebraska

William Newton, Associate Editor/Senior Writer Views
Key briefs were filed in Colorado and Nebraska in ongoing state 340B contract pharmacy litigation.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

News Alert

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

Shannon Young, Associate Editor/Senior Writer Views
U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live